![Effect of Concomitant Disease-modifying Antirheumatic Drugs and Methotrexate Administration Route on Biologic Treatment Durability in Rheumatoid Arthritis: OBRI Cohort Results | The Journal of Rheumatology Effect of Concomitant Disease-modifying Antirheumatic Drugs and Methotrexate Administration Route on Biologic Treatment Durability in Rheumatoid Arthritis: OBRI Cohort Results | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/46/8/874/F1.large.jpg)
Effect of Concomitant Disease-modifying Antirheumatic Drugs and Methotrexate Administration Route on Biologic Treatment Durability in Rheumatoid Arthritis: OBRI Cohort Results | The Journal of Rheumatology
![Biomedicines | Free Full-Text | Folate-Targeted Liposomal Formulations Improve Effects of Methotrexate in Murine Collagen-Induced Arthritis Biomedicines | Free Full-Text | Folate-Targeted Liposomal Formulations Improve Effects of Methotrexate in Murine Collagen-Induced Arthritis](https://www.mdpi.com/biomedicines/biomedicines-10-00229/article_deploy/html/images/biomedicines-10-00229-ag.png)
Biomedicines | Free Full-Text | Folate-Targeted Liposomal Formulations Improve Effects of Methotrexate in Murine Collagen-Induced Arthritis
![Frontiers | Polymeric Nanoscale Drug Carriers Mediate the Delivery of Methotrexate for Developing Therapeutic Interventions Against Cancer and Rheumatoid Arthritis | Oncology Frontiers | Polymeric Nanoscale Drug Carriers Mediate the Delivery of Methotrexate for Developing Therapeutic Interventions Against Cancer and Rheumatoid Arthritis | Oncology](https://www.frontiersin.org/files/MyHome%20Article%20Library/549178/549178_Thumb_400.jpg)
Frontiers | Polymeric Nanoscale Drug Carriers Mediate the Delivery of Methotrexate for Developing Therapeutic Interventions Against Cancer and Rheumatoid Arthritis | Oncology
PLOS ONE: Peptide Carrier-Mediated Non-Covalent Delivery of Unmodified Cisplatin, Methotrexate and Other Agents via Intravenous Route to the Brain
![Folitrax Methotrexate Injection, Packaging: Vial, Ipca Laboratories Ltd, Rs 101 /unit | ID: 22468663448 Folitrax Methotrexate Injection, Packaging: Vial, Ipca Laboratories Ltd, Rs 101 /unit | ID: 22468663448](https://5.imimg.com/data5/XC/XS/WE/SELLER-109604861/methotrexate-injection-500x500-250x250.jpg)
Folitrax Methotrexate Injection, Packaging: Vial, Ipca Laboratories Ltd, Rs 101 /unit | ID: 22468663448
![Comparison of the effects of weekly methotrexate (MTX) dose, route of... | Download Scientific Diagram Comparison of the effects of weekly methotrexate (MTX) dose, route of... | Download Scientific Diagram](https://www.researchgate.net/profile/Abdel-Qader-Albawab/publication/283208946/figure/fig2/AS:293954651213855@1447095658590/Comparison-of-the-effects-of-weekly-methotrexate-MTX-dose-route-of-administration-and.png)
Comparison of the effects of weekly methotrexate (MTX) dose, route of... | Download Scientific Diagram
![Methotrexate Nanoparticles Prepared with Codendrimer from Polyamidoamine (PAMAM) and Oligoethylene Glycols (OEG) Dendrons: Antitumor Efficacy in Vitro and in Vivo | Scientific Reports Methotrexate Nanoparticles Prepared with Codendrimer from Polyamidoamine (PAMAM) and Oligoethylene Glycols (OEG) Dendrons: Antitumor Efficacy in Vitro and in Vivo | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsrep28983/MediaObjects/41598_2016_Article_BFsrep28983_Fig7_HTML.jpg)
Methotrexate Nanoparticles Prepared with Codendrimer from Polyamidoamine (PAMAM) and Oligoethylene Glycols (OEG) Dendrons: Antitumor Efficacy in Vitro and in Vivo | Scientific Reports
![Methotrexate for Inflammatory Bowel Disease: Pharmacology and Preliminary Results - Mayo Clinic Proceedings Methotrexate for Inflammatory Bowel Disease: Pharmacology and Preliminary Results - Mayo Clinic Proceedings](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/905367/6623020/gr1.gif)
Methotrexate for Inflammatory Bowel Disease: Pharmacology and Preliminary Results - Mayo Clinic Proceedings
![These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or ... These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or ...](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=Methotrexate-Carton1.jpg&id=567692)
These highlights do not include all the information needed to use METHOTREXATE INJECTION safely and effectively. See full prescribing information for METHOTREXATE INJECTION. METHOTREXATE injection, for intravenous, intramuscular, subcutaneous, or ...
![Oral to subcutaneous methotrexate dose-conversion strategy in the treatment of rheumatoid arthritis | Semantic Scholar Oral to subcutaneous methotrexate dose-conversion strategy in the treatment of rheumatoid arthritis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0a12345c768301c264f3e55555087fa6f1d53f9a/3-Table1-1.png)